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Key questions
What is already known about this subject?
 ► Patients with unstable angina have a low mortal-
ity and a low rate of obstructive coronary artery 
disease.
 ► Applying symptom characteristics to traditional risk 
factors improves risk prediction models in patients 
with stable angina.
What does this study add?
 ► This study demonstrates that by structuring symp-
tom characteristics and clinical variables it is possi-
ble to improve pre-test selection beyond guidelines 
risk criteria.
How might this impact on clinical practice?
 ► Better pre-test selection criteria for acute coronary 
angiography in patients with unstable angina would 
reduce cost for healthcare systems and avoid expos-
ing patients to unnecessary risk of complications.
 ► Prospective studies are needed to validate our 
findings.
AbstrAct
Objective Patients referred for acute coronary 
angiography (CAG) with unstable angina (UA) have low 
mortality and low rate of obstructive coronary artery 
disease (CAD). Better pre-test selection criteria are 
warranted. We aimed to assess the current guidelines 
against other clinical variables as predictors of obstructive 
CAD in patients with UA referred for acute CAG.
Methods From 2005 to 2012, all CAGs performed at the 
University Hospital of North Norway, the sole provider of 
CAG in the region, were recorded in a registry. We included 
979 admissions of UA and retrospectively collected data 
regarding presenting clinical parameters from patient 
hospital records. Obstructive CAD was defined as ≥50% 
stenosis and considered prognostically significant if found 
in the left main stem, proximal LAD or all three main 
coronary arteries. Characteristics were analysed by logistic 
regression analysis. A score was developed using ORs 
from significant factors in a multivariable model.
Results The overall rate of obstructive CAD was 45%, 
and the rate of prognostically significant CAD was 11%. 
The risk criteria recommended in American College of 
Cardiology/American Heart Association and European 
Society of Cardiology guidelines had an area under the 
curve (AUC) of 0.58. Adding clinical information increased 
the AUC to 0.77 (95% CI 0.74 to 0.80). Applying the 
derived score, we found that 56% (n=546) of patients had 
a score of <13, which was associated with a negative 
predictive value of 95% for prognostic significant CAD.
Conclusions The current results suggest that CAG may 
be postponed or cancelled in more than half of patients 
with UA by improving pre-test selection criteria with the 
addition of clinical parameters to current guidelines.
IntROduCtIOn
Acute chest pain is one of the most common 
presenting symptoms in emergency depart-
ments.1 It poses a challenge to health-
care systems as critical conditions require 
prompt diagnosis and treatment, whereas 
benign disorders need to be identified early 
to prevent unnecessary and potentially 
harmful procedures. Suspected acute coro-
nary syndrome refers to patients with chest 
pain presumably caused by acute myocar-
dial ischaemia and encompasses myocardial 
infarction (MI) and unstable angina (UA). 
Patients with UA have no evidence of myocar-
dial injury.2 3 New, high-sensitive cardiac 
troponin (hs-cTn) assays detect myocardial 
injury in a group of patients previously diag-
nosed as UA, thus changing the diagnosis to 
MI.4–6 Consequently, the present UA popula-
tion have lower mortality and are less likely 
to have obstructive coronary artery disease 
(CAD).5 7 8
Despite this, the fear of missing an 
impending MI results in a liberal referral 
practice of patients with presumed UA to 
acute coronary angiography (CAG). Euro-
pean Society of Cardiology (ESC) and Amer-
ican College of Cardiology/American Heart 
Association (ACC/AHA) guidelines for the 
management of acute coronary syndrome in 
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patients without ST elevation recommend performing 
CAG within 72 hours if there is either an intermediate 
Global Registry of Acute Coronary Events (GRACE) risk 
score (109–140), relevant comorbidity, recurrence of 
symptoms or a positive ECG or stress test.3 9 GRACE risk 
score predicts the risk of MI and death and is included 
in the guidelines as a tool to risk stratify these patients.10
A better pre-test selection is warranted. We aimed to 
assess the GRACE risk score, guidelines risk criteria and 
other clinical factors capability of predicting obstructive 




Between 1 January 2005 and 31 December 2012, all coro-
nary angiographies (CAG) performed at the University 
Hospital of North Norway were recorded in a clinical 
registry. The University Hospital is the sole provider of 
CAG in Northern Norway, serving a local population 
of 127 000 and a total regional population of 481 000. 
We included the 1936 CAGs performed in patients with 
presumed UA from the local catchment area to facili-
tate further retrospective data collection from patient 
hospital records. Patients with more than one proce-
dure per admission were only included once (n=35), 
and patients with a peak troponin level above the 99th 
percentile (n=813) were excluded.2 We also excluded 
patients mislabelled as UA (n=46) and patients with other 
primary local hospitals (n=30), incorrectly registered 
as local patients. Patients who had undergone percuta-
neous coronary intervention (PCI) within the last 30 days 
(n=33) were excluded because 91% of these patients had 
obstructive CAD, warranting acute CAG. Subsequently, 
the final cohort included 979 UA patient admissions.
data collection
The registry contains data from all consecutive CAGs, 
recorded by the operator at the time of the procedure. 
Linkage to troponin levels from the Department of Clin-
ical Chemistry at the University Hospital of North Norway 
and to patient hospital records was done by the national 
11-digit identification number. From patient hospital 
records, we retrospectively collected data on symptoms 
and clinical findings at presentation, preceding symp-
toms, stress tests, risk factors, comorbidities and medica-
tion. The extent of CAD was evaluated by the interven-
tional cardiologist. In patients with prior coronary artery 
bypass grafting, only those with new obstructive CAD were 
labelled with obstructive CAD. From July 2009, hs-cTnT 
replaced standard troponin assay. A standard troponin 
value of 10 ng/L corresponds to 30 ng/L hs-cTnT. To 
adjust for this, the troponin values measured up to July 
2009 were multiplied by a factor of three.11 12 In addition, 
we performed sensitivity analyses on the subpopulation 
with measured hs-cTnT.
Patients were referred as UA if chest pain at rest, 
new-onset angina or rapidly worsening angina. We regis-
tered the threshold of angina prior to admission by 
the Canadian Cardiovascular Society grading of angina 
pectoris. A variation in the threshold of angina of two 
or more grades was defined as a variable threshold. A 
declining threshold of angina was not included as a vari-
able threshold. Refractory angina was recorded if intra-
venous nitroglycerine was given. We defined a history 
of typical angina as (1) substernal chest pain or discom-
fort, (2) provoked by physical exertion or emotional 
stress and (3) relieved by rest within minutes. Atypical 
angina was defined as two of these characteristics, and 
patients with one of these characteristics were defined 
as having non-anginal chest pain.13 A positive stress 
ECG was defined as ≥1 mm of ST-segment depression 
or elevation, or stress-induced chest pain. The guideline 
criterion of acute heart failure was defined as Killip class 
II–IV. We calculated the GRACE risk score according to 
the Fox model for death between hospital admission and 
6 months (http://www. outcomes- umassmed. org/ grace/ 
files/ GRACE_ RiskModel_ Coefficients. pdf). Family 
history of CAD was defined as first-degree relatives with 
premature CAD stated in the patient hospital record. 
Diabetes mellitus was defined if the diagnosis occurred 
in the patient hospital records or HbA1c≥6.5%. Hyper-
cholesterolaemia was defined by the use of lipid-lowering 
drugs or serum cholesterol level of ≥6.5 mmol/L.
endpoint
As the mortality is very low in patients with UA in the 
hs-cTn era, we chose obstructive CAD as the primary 
endpoint of our analyses. To ensure high sensitivity, 
obstructive CAD was defined as ≥50% angiographic diam-
eter stenosis or fraction flow reserve <0.8 in any epicar-
dial coronary artery.14 We defined obstructive CAD in the 
main stem, proximal left anterior descending artery or in 
all three main coronary vessels (three-vessel disease) as 
prognostically significant CAD.14 15 UA resembles stable 
angina, both having negative hs-cTn and low mortality 
compared with MI, and an unsure prognostic benefit of 
revascularisation. Therefore, we assumed no immediate 
yield of acute revascularisation in the hs-cTn-negative UA 
patients without prognostically significant CAD.
statistical analysis
Patient characteristics were reported as counts, percent-
ages or means±SD. Logistic regression analysis was used 
to investigate predictors of obstructive CAD. In the final 
multivariable model, we included the predictors with 
clinical significance and p<0.05. We included interaction 
terms significantly improving the model by receiver oper-
ating characteristics (ROC) and the Net Reclassification 
Improvement. The Hosmer-Lemeshow goodness-of-fit 
test was not significant for the final model. To investigate 
the main contributing variables of the GRACE risk score 
and guidelines risk criteria, we used a forward selection 
logistic regression analysis, with inclusion at p<0.05.
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Table 1 Patient characteristics
Obstructive CAD
(n=443)
No obstructive CAD 
(n=536) P values
Age (years) 65±11 60±12 <0.001
Male gender (%, n) 67% (297) 52% (281) <0.001
BMI (kg/m2) 28±5 28±6 0.543
Heart rate (beats/min) 68±14 71±16 0.014
Systolic blood pressure (mm Hg) 145±22 140±21 <0.001
Diastolic blood pressure (mm Hg) 81±12 80±13 0.223
Use of antihypertensive drugs (%, n) 77% (339) 63% (339) <0.001
Hypercholesterolaemia (%, n) 74% (326) 66% (352) 0.008
Diabetes mellitus (%, n) 18% (79) 15% (82) 0.287
Established coronary artery disease (%, n) 59% (263) 39% (209) <0.001
  Previous MI (%, n) 36% (158) 21% (113) <0.001
  Previous PCI (%, n) 46% (205) 33% (177) <0.001
  Previous CABG (%, n) 18% (80) 14% (74) 0.069
Family history of CAD (%, n) 50% (220) 53% (285) 0.274
Smoking status 0.008
  Current smoker (%, n) 29% (130) 27% (143)
  Former smoker (%, n) 44% (195) 38% (201)
GRACE risk score 83±22 76±24 <0.001
Values are % (n) or mean±SD.
BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; GRACE, Global Registry of Acute Coronary 
Events; MI, myocardial infarction; PCI, percutaneous coronary intervention.
We found that an increasing number of variables with 
missing information was significantly associated with no 
obstructive CAD (odds ratio (OR) 0.77, 95% confidence 
interval (CI) 0.71 to 0.83). We tested this assumption for 
all variables included in the final model; it was found 
to be true for all variables except symptom characteris-
tics. Therefore, missing information was combined in 
the reference group for the other variables, but classi-
fied as an independent predictive category for symptom 
characteristics.
We created a score based on the final multivariable 
model, weighting the variables with the OR rounded off 
to the nearest integer. Applying the score, we estimated 
the proportion of patients with a high negative predictive 
value (NPV) for prognostically significant CAD, assuming 
these patients could have been safely discharged without 
a CAG or referred for elective CAG. The discriminative 
performance of the GRACE risk score, the ESC and ACC/
AHA guidelines risk criteria, and the derived model and 
its score were tested by ROC analysis. Statistical analyses 
were performed with Stata V.14.0. All reported differ-
ences had two-sided p values<0.05.
Results
Patient characteristics
Of the 979 patients with UA, the overall rate of obstructive 
CAD was 45% (n=443), falling from 56% (n=70) in 2005 
to 29% (n=33) in 2012 (p for trend<0.001). Obstructive 
CAD of prognostic significance was prevalent in 11% 
(n=103) of the patients. Patient characteristics are shown 
in table 1. Patients with obstructive CAD were older, more 
often male, smoked more, had more hypertension and 
hypercholesterolaemia, a higher GRACE risk score and a 
higher rate of established CAD.
Performance of GRACe risk score and risk criteria from 
guidelines
We found that both patients with and without obstruc-
tive CAD had low GRACE risk scores, 83 versus 76, 
respectively. In total, <1% (n=7) of the patients with UA 
had a high GRACE risk score (>140) and 11% (n=104) 
had an intermediate GRACE risk score (109–140). In 
patients with a high GRACE score, five out of seven 
patients had obstructive CAD versus half of the patients 
with an intermediate GRACE score. According to the 
ESC guidelines, 21% (n=202) of the patients in our 
study were candidates for a selective invasive strategy 
based on the results of a non-invasive stress test. 
However, 26% (n=52) of these patients had obstructive 
CAD and 5.5% (n=11) had prognostic significant CAD. 
ACC/AHA guidelines would allocate conservative treat-
ment to 31% (n=299) of the patients, of which 32% 
(n=96) had obstructive CAD and 4.3% (n=13) prog-
nostic significant CAD. High-risk criteria from ESC and 
ACC/AHA guidelines were present in 25% (n=242) 
and 22% (n=216) of the patients, respectively. These 
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Figure 1 Prediction of obstructive coronary artery disease in unstable angina patients referred for coronary angiography. 
Receiver operating characteristics curves for age, Global Registry of Acute Coronary Events (GRACE) risk score, European 
Society of Cardiology (ESC) and American College of Cardiology/American Heart Association (ACC/AHA) guidelines risk 
criteria, and the new risk score model. AUC, area under the curve.
patients did not have more CAD than patients with 
intermediate-risk criteria.
GRACE risk score, ESC and ACC/AHA guidelines had 
similar area under the curve (AUC) for obstructive CAD, 
with AUC of 0.59 (95% CI 0.55 to 0.62), 0.58 (95% CI 
0.56 to 0.61) and 0.58 (95% CI 0.55 to 0.61), respectively. 
Age alone had a significantly higher AUC of 0.61 (95% CI 
0.58 to 0.65, p=0.037) (figure 1). The main contributing 
variables in the GRACE risk score and guidelines risk 
criteria were age, systolic blood pressure at admission, 
prior PCI, Killip class and a positive stress test. We did not 
find more ST-T abnormalities in the ECG of patients with 
obstructive CAD.
Prediction of obstructive coronary artery disease
A history of typical angina symptoms, Canadian Cardio-
vascular Society angina grade 3 or 4, no variable threshold 
of exertional angina, no history of palpitations, prior PCI, 
positive stress testing, smoking, hypertension, age >65 
years and male gender all added independently signifi-
cant information in a multivariable model, increasing the 
AUC for obstructive CAD to 0.77 (95% CI 0.74 to 0.80, 
p<0.001) (table 2, figure 1), significantly higher than the 
GRACE risk score and guidelines risk criteria. The signifi-
cant interaction term between age and prior PCI was also 
included. From the model, we derived a score predicting 
obstructive CAD with an OR of 1.40 (95% CI 1.33 to 1.47, 
p<0.001) per score level increase. With a cut-off level of 
<13, the NPV was 95% for prognostic significant CAD 
in 56% (n=546) of patients with UA referred for acute 
CAG. For the 44% (n=295) of patients with a score <12 
the NPV was 97%. Stratified by sex, a cut-off level of <14 
gave a negative predictive value of 95% for 82% (n=330) 
of females, and a cut-off level of <12 and<13 gave NPVs 
of respectively 96% for 20% (n=177) and 93% for 43% 
(n=251) of males (table 3).
In univariable analysis, shorter pain duration predicted 
obstructive CAD (<2–6 hours, OR 1.82, 95% CI 1.34 to 
2.48, p<0.001), whereas chest pain related to change 
in body posture (n=23) gave lower odds for obstructive 
CAD (OR 0.18, 95% CI 0.05 to 0.68). We found that pain 
relief by nitrates, dyspnoea, pain radiation and number 
of chest pain episodes during the last 24 hours were not 
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OR (95% CI) Score
Age >65 years 410 1.92 (1.49 to 2.49) 2.94 (1.97 to 4.41) 3
Male gender 578 1.85 (1.42 to 2.40) 2.03 (1.48 to 2.79) 2
Prior PCI 382 1.75 (1.35to 2.26) 1.85 (1.21 to 2.81) 2
Hypertension*
  1 303 2.79 (1.82 to 4.28) 2.26 (1.36 to 3.75) 2
  2 151 2.27 (1.40 to 3.69) 2.08 (1.20 to 3.61) 2
  3 372 3.05 (2.01 to 4.63) 2.36 (1.43 to 3.89) 2
Current smoker 273 1.48 (1.06 to 2.06) 2.53 (1.70 to 3.77) 3
Previous smoker 396 1.58 (1.17 to 2.14) 1.37 (0.97 to 1.95) 1
Positive stress test 278 1.60 (1.21 to 2.11) 1.85 (1.34 to 2.56) 2
Best CCS grade
  1 84 1.59 (1.01 to 2.51) 0.91 (0.54 to 1.56) 0
  2 91 2.12 (1.36 to 3.30) 1.05 (0.62 to 1.78) 0
  3–4 107 4.71 (2.97 to 7.48) 1.83 (1.03 to 3.26) 2
No variable threshold† 253 4.03 (2.96 to 5.48) 1.96 (1.28 to 2.99) 2
Symptoms before admission
  Non-anginal pain 243 2.50 (1.58 to 3.96) 1.89 (1.14 to 3.14) 2
  Atypical angina 284 5.75 (3.67 to 9.01) 3.40 (2.01 to 5.75) 3
  Typical angina 141 6.49 (3.90 to 10.8) 3.65 (1.99 to 6.69) 4
  Missing 145 3.10 (1.87 to 5.12) 2.36 (1.36 to 4.08) 2
No palpitations 844 1.93 (1.26 to 2.94) 1.71 (1.07 to 2.74) 2
Interaction: prior PCI and age >65 years 0.50 (0.28 to 0.91) –2
AUC 0.77 (0.74 to 0.80)
*(1) Use of antihypertensive drugs and normal blood pressure on admission, (2) high blood pressure on admission, (3) 1+2.
†No random variation in the threshold of angina defined by two or more CCS grades.
AUC, area under the curve; CCS, Canadian Cardiovascular Society grading of angina pectoris; PCI, percutaneous intervention .








≤5 25 – – –
6–7 54 4 (7.4%) – 3 (5.6%)
8 74 15 (20%) 2 (2.7%) 15 (20%)
9 53 12 (23%) 2 (3.8%) 12 (23%)
10 114 26 (23%) 3 (2.6%) 23 (20%)
11 106 42 (40%) 7 (6.6%) 35 (33%)
12 120 49 (41%) 12 (10%) 36 (30%)
13 101 56 (55%) 17 (17%) 46 (46%)
14 90 63 (70%) 11 (12%) 51 (57%)
15 84 49 (58%) 10 (12%) 46 (55%)
16–17 97 78 (80%) 23 (24%) 69 (71%)
≥18 61 49 (80 %) 16 (26%) 46 (75%)
AUC 0.77 (0.74–0.79) 0.72 (0.68–0.77) 0.75 (0.71–0.78)
AUC, area under the curve; CAD, coronary obstructive artery disease.
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associated with obstructive CAD. Neither were chest wall 
pain, pain related to breathing or self-reported similarity 
to prior CAD symptoms, but most patient records lacked 
this information. A GRACE risk score ≥109 was not signifi-
cantly associated with obstructive CAD (OR 1.37, 95% CI 
0.92 to 2.04).
In sensitivity analyses of the 340 patients included after 
the implementation of hs-cTnT, the AUC of the multi-
variabel model improved from 0.77 (95% CI 0.74 to 0.80) 
to 0.81 (95% CI 0.76 to 0.85, although with larger CIs) 
(online supplementary Table 1). The derived risk score 
performed similarly on the subpopulation with OR of 
1.39 (95% CI 1.28 to 1.52). With a cut-off level of <13, we 
were able to exclude or delay 59% of the patients (n=201) 
to acute CAG with an NPV of 96% for prognostic CAD. 
Further, with a cut-off level of <9 the score demonstrated 
an NPV of 96% for any obstructive CAD in 21% of the 
patients (n=73) (online supplementary Table 2).
dIsCussIOn
In our population-based cohort, we have demonstrated 
that patients with presumed UA referred for acute CAG 
have low rates of obstructive CAD and low GRACE risk 
score. By implementing symptom characteristics and 
clinical information in a new risk score, it was possible to 
rule out a higher number of patients with lower rates of 
obstructive CAD than by applying guidelines risk criteria.
There is to our knowledge no other studies using symp-
toms to predict obstructive CAD in patients with UA. 
The HEART score includes the clinicians’ suspicion of 
critical disease to predict the risk of MI, PCI, CABG and 
death in an all-cause chest pain population.16 In stable 
angina, typical angina symptoms added to risk scores is 
known to improve the prediction of obstructive CAD.17 18 
In our study, we found that a history of typical angina 
with a stable or consistently decreasing threshold in the 
time prior to the acute admission was strongly associated 
with obstructive CAD. The acute presentation leading to 
admission was of less importance. Traditional risk factors 
such as age and smoking were also strongly associated 
with obstructive CAD, followed by male gender, hyper-
tension and prior PCI. Age however, was significantly 
reduced as risk factor for those with prior PCI. This led to 
a positive interaction term in the model and could indi-
cate a protective effect of PCI, secondary prevention or 
most likely both.
the definition of unstable angina
Our population underwent clinical decision-making 
before referral. However, with rates of obstructive CAD 
as low as 29% in the end of the study period, patient 
selection was poor. It seems other aetiologies for chest 
pain dominated. We found that palpitations, a known 
symptom of panic disorder, was associated with lack of 
obstructive CAD on invasive angiography.19 Gastrointes-
tinal, musculoskeletal and panic disorders are all known 
to be highly prevalent in patients with acute or stable 
chest pain and no evidence of myocardial ischemia, and 
were likely prevalent in our population.20–22
Braunwald and Morrow suggested that increasingly 
sensitive troponins would make UA a redundant diag-
nosis.23 However in clinical practice, UA remains a chal-
lenging diagnosis as objective criteria are rarely present. 
The fear of uncertainty among clinicians and patients 
may lead to overuse of presumed UA as indication for 
acute CAG, even in patients with low clinical suspicion 
of CAD. This is a likely cause for the low rates of obstruc-
tive CAD in our population. Despite the low prevalence 
of CAD in our population, 79% satisfied the guidelines 
criteria for acute CAG within 72 hours, which in our 
opinion warrants better pre-test selection criteria.
Relevance of guidelines risk criteria and GRACe risk score in 
the unstable angina population
The GRACE risk score predicts 3-year mortality in acute 
coronary syndrome with a superior AUC of 0.82.10 The 
overall low GRACE score observed in both patients with 
and without obstructive CAD is reassuring and supports 
a low mortality in the present-day UA population. It may 
also explain why the GRACE risk score and guidelines 
encompassing non-ST elevation MI (NSTEMI) had poor 
discriminative ability for obstructive CAD in patients with 
UA.3 10 The low mortality of hs-cTn-negative UA is also 
demonstrated in other studies, with a 90-day mortality 
and MI rate for hs-cTnT-negative UA patients of 0.6% 
and 1.7%, respectively.8 Even high-risk UA have a 30-day 
combined death and MI rate of approximately 2%.7 24
Guidelines for NSTEMI/UA recommend an invasive 
approach in many patients with UA, but the implications 
of an invasive strategy are not known. Available trials do 
not report separate findings for patients with or have not 
implemented hs-cTn assays to discriminate between MI 
and UA. Meta-analyses of existing trials up to 2015 differ 
in opinion of the benefit of routine revascularisation for 
the combined UA and NSTEMI population.25–28 It seems 
likely that hs-cTn-negative UA patients will have less 
benefit than NSTEMI patients.
The low rate of obstructive CAD, MI and death, as well 
as an unsure prognostic benefit of revascularisation in the 
hs-cTn-negative UA patients, questions the resource utili-
sation of acute CAG in most patients with UA. Our study 
indicates that it is possible to rule out or delay CAG in 
more than half of the patients with UA by implementing 
a new risk score with symptoms characteristics and clin-
ical information in addition to risk criteria in guidelines.
strengths and limitations
The major strengths of our study are the inclusion of all 
consecutive CAGs performed on the indication of UA 
within a confined geographical area for eight subsequent 
years, and that all variables included in our risk score are 
obtained in daily clinical practice. A potential limitation 
is the relatively small numbers of patients with prognostic 
significant CAD. We have exclusively investigated patients 
with UA referred for CAG, and thereby do not know how 
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the score performs in an extended chest pain/UA popu-
lation. The accuracy and consistency of the retrospective 
information collected from hospital records as well as 
many missing variables are further limitations. To mini-
mise observer bias, the data collection was blinded for the 
CAG result. However, if the CAG was soon after followed 
by coronary artery bypass grafting or gastroscopy, this 
was visible to the data collector, indicating positive or 
negative findings of the CAG result, respectively. Since 
we excluded patients with PCI within 30 days, we could 
not test the post-MI angina criterion, and the ACC/AHA 
criterion of PCI within 6 months was only applied for 1–6 
months. Further, we did not have enough information 
on ESC guidelines’ recurrence of symptoms to validate 
its potential role. We used the peak troponin value to 
define patients with MI. Therefore, we cannot exclude a 
significant bias due to the exclusion of UA patients with 
chronic hs-cTn elevation without a significant rise and/
or fall (eg, due to chronic heart failure or severe renal 
dysfunction). However, as these patients have a higher 
risk of CAD, the authors believe that these patients 
usually should be offered CAG on a lower threshold and 
should be addressed in own focused prospective studies. 
As the adjustment for standard troponin to hs-cTnT was 
only applicable for patients with troponin values above 
the limit of detection, we may have included NSTEMI 
patients before the implementation of hs-cTnT in 2009.
COnClusIOns
Our results suggest that by structuring symptom charac-
teristics and clinical variables it may be possible to post-
pone or cancel acute CAG in over half of the patients 
referred with presumed UA. This would reduce cost for 
healthcare systems, avoid exposing patients to unneces-
sary risk of complications and release capacity for more 
critical diagnoses. Prospective studies are needed to vali-
date our findings.
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